ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
- PMID: 32334082
- PMCID: PMC7194639
- DOI: 10.1016/j.cgh.2020.04.040
ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that causes coronavirus disease 2019 (COVID-19) in human beings, has caused a serious public health issue.1 Attention to pancreatic injury is lacking, which may impact patients' prognosis. In this study, we explored the expression and distribution of angiotensin-converting enzyme 2 (ACE2), the receptor of SARS-CoV-2, in the pancreas. Combined with clinical data, we showed that pancreatic injury can occur in some COVID-19 patients.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Serum Lipase Elevations in COVID-19 Patients Reflect Critical Illness and not Acute Pancreatitis.Clin Gastroenterol Hepatol. 2021 Sep;19(9):1982-1987. doi: 10.1016/j.cgh.2021.04.019. Epub 2021 Apr 18. Clin Gastroenterol Hepatol. 2021. PMID: 33882344 Free PMC article. No abstract available.
References
-
- Badalov N., Baradarian R., Iswara K. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007;5:648–661. - PubMed
-
- Yang J.K., Feng Y., Yuan M.Y. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623–628. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
